Global clinical trials are scheduled to begin after IND approval is received for phase 2 trials in the US and Europe. Breastfeeding may reduce the impact of maternal smoking on lung cancer mortality in adult offspring. The primary end point of the RESILIENT trial was OS. State tobacco quitlines are "uniquely positioned to inform smokers about radon." The approval is based on results from the phase 3 ALINA study. DNA methylation patterns may lend clues to the elusive etiology of lung cancer in people who have never smoked. Dr. Marisa Bittoni discusses the possible link between vaping and lung cancer risk. Cancer organoid-based drug sensitivity tests have recently been investigated to predict responses to anticancer drugs. A study that assessed the impact of miR-29a and miR-143 on gene expression in lung cancer. Patient-derived organoids have shown promise in modeling cancer therapy response. A study that examined whether the combination of AI and knowledge can identify more patients with lung and ovarian cancers. A study examined whether AI and clinical knowledge can identify more patients with lung and ovarian cancers. A study detailed the landscape of lung adenocarcinoma progression. MK-1084 as monotherapy and in combination with pembrolizumab is effective in patients with NSCLC. Positive trial results and FDA approvals have changed the standard of care for NSCLC. The timing of chemotherapy given to patients with SCLC does not have a statistically significant impact on OS. The timing of chemotherapy given to patients with SCLC does not have a statistically significant effect on OS. Lung cancer screening discussions are not happening as often as they could be among health care providers. The postoperative comfort scale has good reliability and validity, and can be used to assess patients with lung cancer. Just under a quarter of a million new cases of lung cancer were diagnosed in 2023, with 10-20% in non-smokers.